৳ 1,000/unit
Pack: ৳ 12,000
৳ 1,000/unit
Pack: ৳ 12,000
At a glance
Sunitinib is a multi-tyrosine kinase inhibitor used for gastrointestinal stromal tumor (GIST), advanced renal cell carcinoma (RCC), and pancreatic neuroendocrine tumors (pNET).
Indications
- Gastrointestinal stromal tumor (GIST) – after progression on or intolerance to imatinib
- Advanced renal cell carcinoma (RCC)
- Adjuvant treatment of RCC (high risk after nephrectomy)
- Advanced pancreatic neuroendocrine tumors (pNET)
Pharmacology
Sunitinib inhibits multiple receptor tyrosine kinases including PDGFR, VEGFR, KIT, FLT3, CSF-1R, and RET. It blocks signaling pathways involved in tumor cell proliferation, angiogenesis, and metastasis, reducing tumor growth and promoting apoptosis.
Dosage
Adult Dose (Oral):
- GIST/Advanced RCC: 50 mg once daily (4 weeks on, 2 weeks off – 4/2 schedule)
- Adjuvant RCC: 50 mg once daily (4/2 schedule) – nine 6-week cycles
- pNET: 37.5 mg once daily continuously (no scheduled off period)
Side effects
Common Side Effects:
- Nausea, vomiting, weakness
- Diarrhea, constipation
- Hypertension
- Skin discoloration, hair discoloration
- Painful blisters on hands and feet
- Fatigue, fever, loss of appetite, weight loss
Use in pregnancy
Use in Pregnancy: Unsafe; evidence of fetal risk; use only in life-threatening situations; consult your doctor.
Pregnancy Category: D — always consult a doctor before taking during pregnancy.
Precautions & warnings
- Hepatotoxicity: Monitor liver enzymes
- Cardiovascular events, QT prolongation
- Hypertension: Regular monitoring
- Hemorrhage, thrombotic microangiopathy
- Thyroid dysfunction: Regular monitoring
- Hypoglycemia: Caution in diabetic patients
- Wound healing delay: Discontinue before surgery
Overdose effects
No specific antidote for overdose; provide supportive care; if indicated, eliminate unabsorbed drug by emesis or gastric lavage; overdose up to 1500 mg has been reported without adverse reactions.
Storage conditions
Store at 25°C in a cool and dry place, protected from light; keep out of reach of children.